If we see Test receivables over $2.4 million and total revenues any where near $3 million with some decent guidance on Thyroid Reveal uptake this stock could explode higher and never look back. Possible double or triple, let's see tomorrow ....
hey ROOTRASH, they dont have to file b/c they are not an American company. Yes, I am actually surprised that Ken Berlin said what he was going to do 2 years ago and finally file quarterly reports. Hopefully they are good as we are testing the $1 range again idiot!
Luminex Corporation (NASDAQ: LMNX) bought NSPH .... Better sell the company.... Or remove the CEO ... LOL
The moment of truth is coming all those years of promises and forecasting will come to conclusion on this report no more excuses this Report is the most crucial for ROSG it will make or break the company if its bad report well eventually company slowly will died . but good news on the Research side the usage of the testing and strong Financial side will put the company on the High road price easily can double or even triple.
my bet is that its going to be very good report Good luck ROSG
shelf filings are just standard for companies that constantly raise money. doesnt mean that they will dilute but gives them the option to. cant really read a lot into them but CEO Ken Berlin doesnt care about PPS so he will do what is best for HIM not shareholders so dilution is always on the table when it comes to ROSG.
They have been stressing partnerships and hopefully they can attract someone like J&J or other BP to give them some SEED money for future tests or sales so they dont have to keep diluting shares.
Keep in mind, CEO Ken Berlin will do what is best for his salary and NOT for your investment. I would talk Anne Fields at IR and make sure that you tell her that you want to see the company sold and NO MORE DILUTION!